Single, high-dose intramuscular triamcinolone acetonide versus weekly oral methotrexate in life-threatening asthma: a double-blind study.

@article{Ogirala1995SingleHI,
  title={Single, high-dose intramuscular triamcinolone acetonide versus weekly oral methotrexate in life-threatening asthma: a double-blind study.},
  author={R. G. Ogirala and Timo Sturm and Thomas K. Aldrich and F F Meller and Emmanuel Pacia and Aidan M Keane and Richard Finkel},
  journal={American journal of respiratory and critical care medicine},
  year={1995},
  volume={152 5 Pt 1},
  pages={1461-6}
}
Effective and less toxic treatments are needed for patients with severe, steroid-dependent asthma. Both low-dose oral methotrexate and high-dose intramuscular triamcinolone have been recommended for these patients. We compared the effects of these two medications on pulmonary function, peak flow rates, airway reactivity, oral steroid use, emergency room (ER… CONTINUE READING